Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Slevin

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
MCN. the American Journal of Maternal Child Nursing|September 1, 1987
Chlamydia--cause, prevention, and cureC Marvin, A Slevin
Applied Optics|June 29, 2010
Holographic evaluation of ceramic materialsF McLysaght, J A Slevin
Journal of Opioid Management|May 13, 2011
Primary care physician opinion survey on FDA opioid risk evaluation and mitigation strategiesKieran A Slevin, Michael A Ashburn
Anesthesia and Analgesia|February 10, 2011
The efficacy and safety of fentanyl buccal tablet compared with immediate-release oxycodone for the management of breakthrough pain in opioid-tolerant patients with chronic painMichael A Ashburn, Kieran A Slevin, John Messina, et al.
The International Journal of Prosthodontics|May 1, 1995
Lithium ion strengthening of dental porcelainV Piddock, A J Qualtrough, A Slevin, et al.
Acta Neurobiologiae Experimentalis|May 16, 1998
Protein kinase C expression and activity in the human brain after ischaemic strokeJ Krupiński, M A Slevin, P Kumar, et al.
Pain Medicine (Malden, Mass.)|June 23, 2011
Left stellate ganglion blockade for the management of drug-resistant electrical stormRishin A Patel, Debra L Priore, Wilson Y Szeto, et al.
Scientific Reports|May 14, 2017
Optimisation of a Novel Spiral-Inducing Bypass Graft Using Computational Fluid DynamicsAndres Ruiz-Soler, Foad Kabinejadian, Mark A Slevin, et al.
Pain Medicine (Malden, Mass.)|July 17, 2013
Fentanyl buccal tablet compared with immediate-release oxycodone for the management of breakthrough pain in opioid-tolerant patients with chronic cancer and noncancer pain: a randomized, double-blind, crossover study followed by a 12-week open-label phase to evaluate patient outcomesLynn R Webster, Kieran A Slevin, Arvind Narayana, et al.
Biochemical Society Transactions|November 1, 1993
Antiproliferative actions of cyclosporin A on endothelial cells are not exerted through protein kinase C (PkC)B D Edwards, M A Slevin, A J Dickson, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
MCN. the American Journal of Maternal Child Nursing|September 1, 1987
Chlamydia--cause, prevention, and cureC Marvin, A Slevin
Applied Optics|June 29, 2010
Holographic evaluation of ceramic materialsF McLysaght, J A Slevin
Journal of Opioid Management|May 13, 2011
Primary care physician opinion survey on FDA opioid risk evaluation and mitigation strategiesKieran A Slevin, Michael A Ashburn
Anesthesia and Analgesia|February 10, 2011
The efficacy and safety of fentanyl buccal tablet compared with immediate-release oxycodone for the management of breakthrough pain in opioid-tolerant patients with chronic painMichael A Ashburn, Kieran A Slevin, John Messina, et al.
The International Journal of Prosthodontics|May 1, 1995
Lithium ion strengthening of dental porcelainV Piddock, A J Qualtrough, A Slevin, et al.
Acta Neurobiologiae Experimentalis|May 16, 1998
Protein kinase C expression and activity in the human brain after ischaemic strokeJ Krupiński, M A Slevin, P Kumar, et al.
Pain Medicine (Malden, Mass.)|June 23, 2011
Left stellate ganglion blockade for the management of drug-resistant electrical stormRishin A Patel, Debra L Priore, Wilson Y Szeto, et al.
Scientific Reports|May 14, 2017
Optimisation of a Novel Spiral-Inducing Bypass Graft Using Computational Fluid DynamicsAndres Ruiz-Soler, Foad Kabinejadian, Mark A Slevin, et al.
Pain Medicine (Malden, Mass.)|July 17, 2013
Fentanyl buccal tablet compared with immediate-release oxycodone for the management of breakthrough pain in opioid-tolerant patients with chronic cancer and noncancer pain: a randomized, double-blind, crossover study followed by a 12-week open-label phase to evaluate patient outcomesLynn R Webster, Kieran A Slevin, Arvind Narayana, et al.
Biochemical Society Transactions|November 1, 1993
Antiproliferative actions of cyclosporin A on endothelial cells are not exerted through protein kinase C (PkC)B D Edwards, M A Slevin, A J Dickson, et al.
Pageof 2